Alternative Names
Acute lymphoblastic leukemia cells antigen CD38 antibody; ADP ribosyl cyclase 1 antibody; ADP ribosyl cyclase antibody; ADP ribosyl cyclase/cyclic ADP-ribose hydrolase antibody; ADP-ribosyl cyclase 1 antibody; ADPRC 1 antibody; ADPRC1 antibody; cADPr hydrolase 1 antibody; CD 38 antibody; CD38 antibody; CD38 antigen;p45 antibody; CD38 antigen antibody; CD38 molecule antibody; Cd38-rs1 antibody; CD38_HUMAN antibody; CD38H antibody; Cyclic ADP ribose hydrolase antibody; Cyclic ADP ribose hydrolase 1 antibody; Cyclic ADP-ribose hydrolase 1 antibody; EC 3.2.2.5 antibody; Ecto nicotinamide adenine dinucleotide glycohydrolase antibody; I-19 antibody; I19;mouse antibody; Lymphocyte differentiation antigen CD38 antibody; NAD(+ nucleosidase antibody; NIM-R5 antigen antibody; NIMR5 antigen;mouse antibody; OTTHUMP00000158633 antibody; OTTHUMP00000217743 antibody; p45 antibody; T10 antibody; Erzotabart
Immunogen
Recombinant Human CD38 protein
Immunogen Species
Homo sapiens (Human)
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.